Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFG.L Regulatory News (PFG)

  • There is currently no data for PFG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tier 2 Pricing and Senior Bond Tender

7 Oct 2021 07:00

RNS Number : 2728O
Provident Financial PLC
07 October 2021
 

 

 

 

 

Provident Financial plc

Tier 2 Pricing and Senior Bond Tender

 

Provident Financial plc ('PFG' or 'the Group'), the leading provider of credit products to consumers who are underserved by mainstream banks, publishes an update to the market today following the successful pricing of the Group's first Tier 2 subordinated bond since 2005 and the partial tender of its 2023 Senior Bonds.

 

Tier 2 Bond pricing

 

PFG announces today that it has successfully priced its first subordinated debt capital to the external markets since 2005. The pricing is for a £200m Tier 2 bond in pound sterling with a 10.25 year maturity, callable after 5.25 years, and a coupon of 8.875% reflecting the strong interest received from the market and the Group's improving credit narrative. The bond is being priced with an expected rating of B+ (Fitch). The pricing of the bonds represents an important additional step for the Group as it seeks to diversify its sources of capital and funding, and to finance future growth opportunities.

 

Partial tender process

 

A partial tender process for the Group's 2023 Senior Bonds, with an 8.25% coupon, was launched by PFG. The Group successfully repurchased £71.5m of its £175m outstanding 2023 Senior Bonds, which do not count towards the Group's regulatory capital. This is the second time that PFG has successfully launched a partial tender of these bonds, the last time being August 2020 for £75.0m.

 

Neeraj Kapur, Chief Finance Officer, commented:

 

"I am pleased to announce the pricing of PFG's first Tier 2 capital issuance since 2005, alongside a buyback of some of our 2023 Senior Bonds, as we continue to target efficiencies across our capital and funding structure. Following strong demand from investors, we have priced £200m of Tier 2 subordinated debt capital, in a typical form under UK regulation, with a 10.25 year maturity, callable at 5.25 years, and a coupon of 8.875%. The strong support we received from participating investors was excellent and a real endorsement of our strategic objectives moving forwards. In combination with other debt refinancing activities that have been executed since our half year results, this places the Group in a very strong capital and liquidity position."

 

Enquiries:

 

 

 

Analysts and shareholders:

 

 

 

Owen Jones, Group Head of Investor Relations

 

 

07341 007842

Owen.jones@providentfinancial.com

 

 

 

 

Media:

 

 

 

Richard King, Provident Financial

 

 

07919 866876

Nick Cosgrove/Simone Selzer, Brunswick

 

 

0207 4045959

providentfinancial@brunswickgroup.com

 

 

 

 

Distribution Restrictions

Please note that the information contained in this announcement and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus dated 23 September 2021)) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in this announcement, the Final Terms and the Base Prospectus you must ascertain from the Final Terms and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy, securities to any person in the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

The notes referred to in the Final Terms and the Base Prospectus (the "securities") have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the US and are subject to US tax law requirements. Subject to certain exceptions, the securities may not be offered or sold directly or indirectly within the US or to, or for the account or benefit of, US persons or to persons within the US, as such terms are defined in Regulation S under the Securities Act. Any forwarding, distribution or reproduction of the Final Terms or the Base Prospectus in whole or in part is prohibited. Failure to comply with this notice may result in a violation of the Securities Act or the applicable laws of other jurisdictions. There will be no public offering of the securities in the United States.

The Base Prospectus is available at https://www.rns-pdf.londonstockexchange.com/rns/7891M_1-2021-9-23.pdf, the Supplementary Base Prospectus is available at https://www.rns-pdf.londonstockexchange.com/rns/9638N_1-2021-10-4.pdf and the Final Terms (when published) will be available at: https://www.londonstockexchange.com/news?tab=news-explorer.

A rating is not a recommendation to buy, sell or hold securities and may be subject to revision, suspension or withdrawal at any time by the assigning rating organisation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEDQLFBFBLBFBB
Date   Source Headline
2nd Mar 20234:30 pmRNSCompany name change
28th Feb 20234:30 pmRNSTotal Voting Rights
31st Jan 20234:30 pmRNSTotal Voting Rights
31st Jan 20237:00 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSPFG appoints Ian McLaughlin as new CEO
26th Jan 20237:00 amRNSQ4 Trading Update, Product Launch and Name Change
24th Jan 20233:05 pmRNSHolding(s) in Company
13th Jan 20233:00 pmRNSBlock listing Interim Review
4th Jan 20231:00 pmRNSDirector/PDMR Shareholding
30th Dec 20221:30 pmRNSTotal Voting Rights
30th Nov 20224:30 pmRNSTotal Voting Rights
8th Nov 20227:00 amRNSBlock Listing Application
4th Nov 202212:18 pmRNSFunding Update
3rd Nov 202211:18 amRNSHolding(s) in Company
31st Oct 20224:30 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSThird quarter 2022 trading update
3rd Oct 20221:15 pmRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20224:43 pmRNSHolding(s) in Company
16th Sep 20222:21 pmRNSHolding(s) in Company
31st Aug 20224:30 pmRNSTotal Voting Rights
29th Jul 20224:30 pmRNSTotal Voting Rights
27th Jul 20227:00 amRNSInterim results for six months ended 30 June 2022
15th Jul 20223:04 pmRNSBlock listing Interim Review
1st Jul 20221:00 pmRNSDirector/PDMR Shareholding
30th Jun 20224:30 pmRNSTotal Voting Rights
29th Jun 20224:10 pmRNSProvident Financial plc Result of AGM
31st May 20224:30 pmRNSTotal Voting Rights
26th May 20224:25 pmRNSHolding(s) in Company
19th May 20227:00 amRNSProvident Financial plc Q1 2022 Trading Statement
11th May 202211:41 amRNSHolding(s) in Company
3rd May 202210:49 amRNSTotal Voting Rights
21st Apr 202211:32 amRNSDirector/PDMR Shareholding
12th Apr 20224:28 pmRNSHolding(s) in Company
8th Apr 202211:15 amRNSDirector/PDMR Shareholding
7th Apr 20221:34 pmRNSPFG Annual Report and Accounts and AGM Notice
5th Apr 202212:30 pmRNSDirector/PDMR Shareholding
1st Apr 20223:58 pmRNSHolding(s) in Company
1st Apr 20222:00 pmRNSDirector/PDMR Shareholding
31st Mar 20224:30 pmRNSTotal Voting Rights
31st Mar 20227:00 amRNSPFG 2021 Preliminary Results Announcement
24th Mar 20227:00 amRNSAppointment of Managing Director of Cards
22nd Mar 202210:34 amRNSHolding(s) in Company
21st Mar 20229:54 amRNSHolding(s) in Company
28th Feb 20224:30 pmRNSTotal Voting Rights
21st Feb 20224:06 pmRNSDirector Declaration
3rd Feb 20223:51 pmRNSHolding(s) in Company
1st Feb 20225:26 pmRNSHolding(s) in Company
1st Feb 20228:04 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.